Maryland-based Novavax, Inc. announced on January 22, 2021, that it had finalized an agreement with the Government of Canada to supply up to 76 million doses of NVX-CoV2373, the company’s recombinant protein-based COVID-19 vaccine. Canada has... READ →
Coronavirus Today
/ January 23rd, 2021Eliminating fake vaccine news with pharmacist, nurse, and physician review.
For more articles, try our search.